InVitro International Share Price Other OTC
Equities
IVRO
US4618531036
Pharmaceuticals
Sales 2022 | 854K 67.34M | Sales 2023 | 793K 62.54M | Capitalization | 1.3M 103M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 0.29 x |
Net cash position 2022 | 1.23M 97.24M | Net cash position 2023 | 1.13M 89.05M | EV / Sales 2023 | 0.22 x |
P/E ratio 2022 |
69.3
x | P/E ratio 2023 |
885
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.73% |
Managers | Title | Age | Since |
---|---|---|---|
W. Ulmer
CEO | Chief Executive Officer | - | 14/09/19 |
Cathy Richmond
DFI | Director of Finance/CFO | - | 14/09/19 |
Atul Jhalani
PSD | President | - | 02/06/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irwin Gruverman
BRD | Director/Board Member | 89 | 22/09/20 |
Dennis Chenoweth
BRD | Director/Board Member | - | - |
W. Ulmer
CEO | Chief Executive Officer | - | 14/09/19 |
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.68% | 364B | |
+20.12% | 326B | |
+5.45% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.02% | 167B | |
+0.57% | 161B |